WASHINGTON: AIM-listed Venture Life said it expected to report full-year revenues of at least £14m as it order book strengthened in the second half. The 50% jump in forecast revenue was also due to a stronger euro, the consumer self-care company said in a trading statement. “The order book for 2017 is already building steadily and we are pleased to report that the order book for our development and manufacturing business for the month of January 2017 is already 45% higher than actual revenue recognised in January 2016, excluding intercompany sales,” Venture said. It said it had made good progress on the integration of Periproducts since the acquisition of the company and the UltraDEX brand in March 2016.
“Manufacturing processes for the UltraDEX toothpaste and oral rinse products have been fully established at the group’s manufacturing facility in Italy and the first UltraDEX products manufactured in-house have been shipped to customers,” Venture said. “The UltraDEX advertising campaign which launched on 10 October 2016 ran as planned for two weeks and the product sampling activity at certain London railway stations was well-received by consumers.” An advertising campaign for UltraDEX resulted in an uplift in revenue compared to preceding months, in both September and October, Venture said.
